(Total Views: 426)
Posted On: 04/11/2024 2:08:10 PM
Post# of 148870
From what I read, this is what the FDA said about Cytodyn!
CytoDyn shared results from the first instances of leronlimab treatment on critically ill Covid-19 patients in Intensive Care Units in New York—long before there was any clinical data that might provide a basis on which to question the drug’s potential to achieve authorization—an FDA employee commented to colleagues internally “Approval is OUT OF THE QUESTION!!!” and “I HATE THEM[,]”
CytoDyn shared results from the first instances of leronlimab treatment on critically ill Covid-19 patients in Intensive Care Units in New York—long before there was any clinical data that might provide a basis on which to question the drug’s potential to achieve authorization—an FDA employee commented to colleagues internally “Approval is OUT OF THE QUESTION!!!” and “I HATE THEM[,]”
(2)
(0)Scroll down for more posts ▼
